Literature DB >> 23130442

Dengue mortality in patients under 18 years old: an analysis from the health situation analysis of Thai population in 2010 project.

Pagakrong Lumbiganon1, Pope Kosalaraksa, Kaewjai Thepsuthammarat, Sumitr Sutra.   

Abstract

BACKGROUND: Dengue is an important cause of morbidity and mortality in tropical and subtropical regions of the world. In Thailand, there has been no detailed research on mortality in children in terms of duration of admission and associated complications in the cases that died.
OBJECTIVE: To assess the burden of dengue in Thailand in 2010 and to analyze the complications in patients aged under 18 years who died. MATERIAL AND
METHOD: The authors described the mortality and complications of dengue fever and dengue hemorrhagic fever in patients under 18 years old using the information from the Health Situation Analysis of the Thai Population 2010 Project.
RESULTS: In 2010, the overall mortality of dengue in all age groups and in patients aged under 18 years were 0.3 and 0.6/ 100,000, respectively. The mortality rate was highest among children aged 6-12 years (0.8/100,000). Among the 8 children with dengue fever that died, the 2 most common complications were fluid electrolyte and acid-base imbalance and disseminated intravascular coagulation (DIC). The common complications among the 91 cases with dengue hemorrhagic fever that died included fluid electrolyte and acid-base imbalance, hepatic failure, respiratory failure, bacterial infection, DIC and renal failure.
CONCLUSION: Early diagnosis, careful management of fluid therapy, awareness of hepatic and renal impairment and early treatment of co-infection should decrease mortality of dengue hemorrhagic fever

Entities:  

Mesh:

Year:  2012        PMID: 23130442

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

1.  Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool.

Authors:  Luciano Pamplona de Góes Cavalcanti; Deborah Nunes de Melo Braga; Lívia Maria Alexandre da Silva; Marina Gondim Aguiar; Mariana Castiglioni; José Udevanier Silva-Junior; Fernanda Montenegro de Carvalho Araújo; Renata Allana da Costa Pereira; Danielle Lima Malta; Margarida Maria de Lima Pompeu
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

2.  Death by dengue fever in a Brazilian child: a case report.

Authors:  Rafael Henrique Machado Sacramento; Deborah Nunes de Melo Braga; Franciane Fardin Sacramento; Fernanda Montenegro de Carvalho Araújo; Antônio Afonso Bezerra Lima; Margarida Maria de Lima Pompeu; Danielle Malta Lima; Luciano Pamplona de Góes Cavalcanti
Journal:  BMC Res Notes       Date:  2014-11-27

3.  Enhanced Surveillance for Fatal Dengue-Like Acute Febrile Illness in Puerto Rico, 2010-2012.

Authors:  Kay M Tomashek; Aidsa Rivera; Brenda Torres-Velasquez; Elizabeth A Hunsperger; Jorge L Munoz-Jordan; Tyler M Sharp; Irma Rivera; Dario Sanabria; Dianna M Blau; Renee Galloway; Jose Torres; Rosa Rodriguez; Javier Serrano; Carlos Chávez; Francisco Dávila; Janice Perez-Padilla; Esther M Ellis; Gladys Caballero; Laura Wright; Sherif R Zaki; Carmen Deseda; Edda Rodriguez; Harold S Margolis
Journal:  PLoS Negl Trop Dis       Date:  2016-10-11

4.  Addressing challenges faced by insecticide spraying for the control of dengue fever in Bangkok, Thailand: a qualitative approach.

Authors:  Peeradone Srichan; Saranath Lawpoolsri Niyom; Oranut Pacheun; Sopon Iamsirithawon; Supawat Chatchen; Caroline Jones; Lisa J White; Wirichada Pan-Ngum
Journal:  Int Health       Date:  2018-09-01       Impact factor: 2.473

5.  Bayesian spatiotemporal modeling with sliding windows to correct reporting delays for real-time dengue surveillance in Thailand.

Authors:  Chawarat Rotejanaprasert; Nattwut Ekapirat; Darin Areechokchai; Richard J Maude
Journal:  Int J Health Geogr       Date:  2020-03-03       Impact factor: 3.918

6.  Dengue human infection models supporting drug development.

Authors:  James Whitehorn; Vinh Chau Nguyen Van; Cameron P Simmons
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.